Search

Benjamin L. Lebron

Examiner (ID: 7336, Phone: (571)272-0475 , Office: P/1777 )

Most Active Art Unit
1777
Art Unit(s)
1777, 1773
Total Applications
617
Issued Applications
402
Pending Applications
48
Abandoned Applications
180

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7038957 [patent_doc_number] => 20050158391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Azithromycin multiparticulate dosage forms by melt-congeal processes' [patent_app_type] => utility [patent_app_number] => 11/003856 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22338 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158391.pdf [firstpage_image] =>[orig_patent_app_number] => 11003856 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/003856
Azithromycin multiparticulate dosage forms by melt-congeal processes Dec 2, 2004 Abandoned
Array ( [id] => 6905209 [patent_doc_number] => 20050100604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Production method for sustained-release preparation' [patent_app_type] => utility [patent_app_number] => 11/001889 [patent_app_country] => US [patent_app_date] => 2004-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11023 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100604.pdf [firstpage_image] =>[orig_patent_app_number] => 11001889 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/001889
Production method for sustained-release preparation Dec 1, 2004 Abandoned
Array ( [id] => 7038822 [patent_doc_number] => 20050158256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Cosmetics tester and method of manufacturing such a tester' [patent_app_type] => utility [patent_app_number] => 11/001009 [patent_app_country] => US [patent_app_date] => 2004-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2027 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158256.pdf [firstpage_image] =>[orig_patent_app_number] => 11001009 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/001009
Cosmetics tester and method of manufacturing such a tester Dec 1, 2004 Abandoned
Array ( [id] => 7112208 [patent_doc_number] => 20050209664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Electrical devices and anti-scarring agents' [patent_app_type] => utility [patent_app_number] => 10/998349 [patent_app_country] => US [patent_app_date] => 2004-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 140794 [patent_no_of_claims] => 112 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209664.pdf [firstpage_image] =>[orig_patent_app_number] => 10998349 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/998349
Electrical devices and anti-scarring agents Nov 25, 2004 Abandoned
Array ( [id] => 5224745 [patent_doc_number] => 20070254011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Bone Formation Agent and Method of Production' [patent_app_type] => utility [patent_app_number] => 10/580549 [patent_app_country] => US [patent_app_date] => 2004-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6534 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254011.pdf [firstpage_image] =>[orig_patent_app_number] => 10580549 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/580549
Bioabsorbable composite material Nov 24, 2004 Issued
Array ( [id] => 6990539 [patent_doc_number] => 20050089576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Sustained release formulation of a peptide' [patent_app_type] => utility [patent_app_number] => 10/990033 [patent_app_country] => US [patent_app_date] => 2004-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6684 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20050089576.pdf [firstpage_image] =>[orig_patent_app_number] => 10990033 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/990033
Sustained release formulation of a peptide Nov 15, 2004 Abandoned
Array ( [id] => 7098549 [patent_doc_number] => 20050131008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => '42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same' [patent_app_type] => utility [patent_app_number] => 10/987771 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14868 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20050131008.pdf [firstpage_image] =>[orig_patent_app_number] => 10987771 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/987771
42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same Nov 11, 2004 Abandoned
Array ( [id] => 7773085 [patent_doc_number] => 08119161 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Blister pack and solid dosage form therefor' [patent_app_type] => utility [patent_app_number] => 10/519715 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2390 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119161.pdf [firstpage_image] =>[orig_patent_app_number] => 10519715 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/519715
Blister pack and solid dosage form therefor Nov 11, 2004 Issued
Array ( [id] => 5865117 [patent_doc_number] => 20060099247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Liquid, gas and/or vapor phase delivery systems' [patent_app_type] => utility [patent_app_number] => 10/986101 [patent_app_country] => US [patent_app_date] => 2004-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12798 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099247.pdf [firstpage_image] =>[orig_patent_app_number] => 10986101 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/986101
Liquid, gas and/or vapor phase delivery systems Nov 9, 2004 Abandoned
Array ( [id] => 4989433 [patent_doc_number] => 20070155774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Oral formulations of desoxypeganine and thereof uses' [patent_app_type] => utility [patent_app_number] => 10/580485 [patent_app_country] => US [patent_app_date] => 2004-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3123 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20070155774.pdf [firstpage_image] =>[orig_patent_app_number] => 10580485 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/580485
Oral formulations of desoxypeganine and thereof uses Nov 7, 2004 Abandoned
Array ( [id] => 7105176 [patent_doc_number] => 20050107352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Method of treating benign prostatic hyperplasia' [patent_app_type] => utility [patent_app_number] => 10/980570 [patent_app_country] => US [patent_app_date] => 2004-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4042 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107352.pdf [firstpage_image] =>[orig_patent_app_number] => 10980570 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/980570
Method of treating benign prostatic hyperplasia Nov 1, 2004 Abandoned
Array ( [id] => 5912417 [patent_doc_number] => 20060127479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Solvent free taste masked pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 10/961728 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4851 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20060127479.pdf [firstpage_image] =>[orig_patent_app_number] => 10961728 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/961728
Solvent free taste masked pharmaceutical compositions Oct 7, 2004 Abandoned
Array ( [id] => 7250505 [patent_doc_number] => 20050142192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives' [patent_app_type] => utility [patent_app_number] => 10/961871 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16554 [patent_no_of_claims] => 108 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142192.pdf [firstpage_image] =>[orig_patent_app_number] => 10961871 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/961871
Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives Oct 7, 2004 Abandoned
Array ( [id] => 6938632 [patent_doc_number] => 20050112195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Drug coating providing high drug loading and methods for providing same' [patent_app_type] => utility [patent_app_number] => 10/950003 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11193 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112195.pdf [firstpage_image] =>[orig_patent_app_number] => 10950003 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/950003
Drug coating providing high drug loading Sep 22, 2004 Issued
Array ( [id] => 4553967 [patent_doc_number] => 07838033 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-23 [patent_title] => 'Composition for rapid disintegrating tablet in oral cavity' [patent_app_type] => utility [patent_app_number] => 10/945049 [patent_app_country] => US [patent_app_date] => 2004-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 10465 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/838/07838033.pdf [firstpage_image] =>[orig_patent_app_number] => 10945049 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/945049
Composition for rapid disintegrating tablet in oral cavity Sep 20, 2004 Issued
Array ( [id] => 5827157 [patent_doc_number] => 20060062845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Alfuzosin tablets and synthesis' [patent_app_type] => utility [patent_app_number] => 10/943725 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5032 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20060062845.pdf [firstpage_image] =>[orig_patent_app_number] => 10943725 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/943725
Alfuzosin tablets and synthesis Sep 16, 2004 Abandoned
Array ( [id] => 4548112 [patent_doc_number] => 07820200 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment' [patent_app_type] => utility [patent_app_number] => 11/575016 [patent_app_country] => US [patent_app_date] => 2004-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2790 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820200.pdf [firstpage_image] =>[orig_patent_app_number] => 11575016 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/575016
Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment Sep 8, 2004 Issued
Array ( [id] => 7208904 [patent_doc_number] => 20050053639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Partially absorbable fiber-reinforced composites for controlled drug delivery' [patent_app_type] => utility [patent_app_number] => 10/935808 [patent_app_country] => US [patent_app_date] => 2004-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5803 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053639.pdf [firstpage_image] =>[orig_patent_app_number] => 10935808 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/935808
Partially absorbable fiber-reinforced composites for controlled drug delivery Sep 7, 2004 Issued
Array ( [id] => 5710056 [patent_doc_number] => 20060051401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Controlled nanofiber seeding' [patent_app_type] => utility [patent_app_number] => 10/936437 [patent_app_country] => US [patent_app_date] => 2004-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13416 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051401.pdf [firstpage_image] =>[orig_patent_app_number] => 10936437 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/936437
Controlled nanofiber seeding Sep 6, 2004 Abandoned
Array ( [id] => 5709953 [patent_doc_number] => 20060051298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Abuse resistent pharmaceutical dosage and method of making same' [patent_app_type] => utility [patent_app_number] => 10/934223 [patent_app_country] => US [patent_app_date] => 2004-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2105 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051298.pdf [firstpage_image] =>[orig_patent_app_number] => 10934223 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/934223
Abuse resistent pharmaceutical dosage and method of making same Sep 2, 2004 Abandoned
Menu